Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Autistic Disorder × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia, Myeloid, Acute 32 Myelodysplastic Syndromes 30 Multiple Myeloma 28 Lymphoma, Non-Hodgkin 27 Hodgkin Disease 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Graft vs Host Disease 24 Lymphoma 23 Leukemia 23 Hematologic Neoplasms 20 Lymphoma, Mantle-Cell 17 Sarcoma 16 Neoplasms 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16 Tuberous Sclerosis 14 Myeloproliferative Disorders 14 Lymphoma, Large B-Cell, Diffuse 14 Burkitt Lymphoma 14 Breast Neoplasms 14 Recurrence 12 Lymphoma, Follicular 12 Waldenstrom Macroglobulinemia 11 Primary Myelofibrosis 11 Neoplasm Metastasis 11 Lymphoma, B-Cell, Marginal Zone 11 Leukemia, Myelomonocytic, Chronic 11 Neoplasms, Plasma Cell 10 Melanoma 10 Lymphangioleiomyomatosis 10

Interventions

Everolimus 5 ziprasidone 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sirolimus 1 Sevelamer 1 Sertraline 1 Selective Serotonin Reuptake Inhibitors 1 Rocuronium 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1 Molindone 1 Methylprednisolone 1 Medical Marijuana 1 Magnetoencephalography 1 Lurasidone Hydrochloride 1 Labetalol 1 Haloperidol 1 Fosfomycin 1 Clozapine 1 Ciprofloxacin 1 Cidofovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01929642 2021-03-29

RAPT

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

Phase 2 Completed

3 enrolled 10 charts

Autistic Disorder, Tuberous Sclerosis, Self-Injurious Behavior

Data powered by HemOnc (CC BY 4.0) Colophon ⚡